Sequential Treatment with FLAG-IDA Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapse/Refractory or Adverse-Risk Leukemia

被引：1
|
作者：
Wolach, Ofir [1 ]
Shargian-Alon, Liat [1 ]
Raanani, Pia [1 ]
Yeshurun, Moshe [1 ]
机构：
[1] Rabin Med Ctr, Davidoff Canc Ctr, Hematol Inst, Petah Tiqwa, Israel
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷
关键词：
D O I：
10.1016/j.clml.2017.07.068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-136
引用
收藏
页码：S284 / S285
页数：2
相关论文
共 50 条
  • [1] Treatment of Adverse-Risk and Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients with FLAG-IDA ± Venetoclax and CLAG-M: A Monocentric Experience
    Rahme, Ramy
    Vidal, Valerie
    Hueso, Thomas
    Le Meur, Lucie
    Rigal, Marthe
    Ivanoff, Sarah
    Brechignac, Sabine
    De latour, Regis Peffault
    Gardin, Claude
    Braun, Thorsten
    BLOOD, 2023, 142
  • [2] Sequential chemotherapy followed by allogeneic hematopoietic stem cell transplantation in patients with refractory acute myeloid leukemia
    Tabares, Salvador
    Garcia, Estefania
    Rojas, Rafael
    Serrano, Josefina
    Ramon Molina, Jose
    Villa, Antonia
    Sanchez, Joaquin
    Martin, Carmen
    Concepcion Arroyo, I.
    BONE MARROW TRANSPLANTATION, 2019, 54 : 612 - 612
  • [3] FLAG-Ida, the possible breakthrough in the treatment of refractory acute myeloid leukemia in the context of hematopoietic stem cell transplantation: Single center experience
    Georgievski, B.
    Veljanovska, A. Pivkova
    Stavric, S. Genadieva
    Stojanoski, Z.
    Cadievski, L.
    Cevreska, L.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5608 - 5609
  • [4] FLAG-ida as a stem cell mobilization regimen in patients with primary refractory or relapsed acute leukemia
    Cagirgan, S
    Pehlivan, M
    Donmez, A
    Talu, P
    Yilmaz, M
    Tombuloglu, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S257 - S257
  • [5] Flag-Ida and donor lymphocyte infusion (DLI) for acute leukemia relapse after allogeneic stem cell transplantation (alloSCT) - single center experience
    Radocha, Jakub
    Zavrelova, Alzbeta
    Lanska, Miriam
    Visek, Benjamin
    Horacek, Jan M.
    Zak, Pavel
    BONE MARROW TRANSPLANTATION, 2018, 53 : 164 - 165
  • [6] Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
    Zucenka, Andrius
    Vaitekenaite, Vilmante
    Maneikis, Kazimieras
    Davainis, Linas
    Pileckyte, Regina
    Trociukas, Igoris
    Peceliunas, Valdas
    Zvirblis, Tadas
    Staras, Vytautas
    Griskevicius, Laimonas
    BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2804 - 2812
  • [7] Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
    Andrius Zucenka
    Vilmante Vaitekenaite
    Kazimieras Maneikis
    Linas Davainis
    Regina Pileckyte
    Igoris Trociukas
    Valdas Peceliunas
    Tadas Zvirblis
    Vytautas Staras
    Laimonas Griskevicius
    Bone Marrow Transplantation, 2021, 56 : 2804 - 2812
  • [8] For Patients with Adverse-Risk Acute Myeloid Leukemia, Frontline FLAG Ida with Venetoclax Is Safe and Efficacious
    Krayem, Baher
    Frisch, Avraham
    Zuckerman, Tsila
    Henig, Israel
    Yehudai-Ofir, Dana
    Nachmias, Boaz
    Khatib, Hazim
    Haran, Arnon
    Aumann, Shlomzion
    BLOOD, 2024, 144 : 4269 - 4270
  • [9] Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia
    Liat Shargian-Alon
    Ofir Wolach
    Uri Rozovski
    Dafna Yahav
    Michal Sela-Navon
    Mazal Rubinstein
    Nino Oniashvilli
    Oren Pasvolsky
    Pia Raanani
    Moshe Yeshurun
    Annals of Hematology, 2020, 99 : 2939 - 2945
  • [10] Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia
    Shargian-Alon, Liat
    Wolach, Ofir
    Rozovski, Uri
    Yahav, Dafna
    Sela-Navon, Michal
    Rubinstein, Mazal
    Oniashvilli, Nino
    Pasvolsky, Oren
    Raanani, Pia
    Yeshurun, Moshe
    ANNALS OF HEMATOLOGY, 2020, 99 (12) : 2939 - 2945
12345